Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Medarex joins forces with Danish investors to develop human antibody therapeutics

March 4, 1999

Cysteine protease-inhibitory peptides disclosed by Takeda

March 2, 1999

New MMP and/or TNF production inhibitors developed by Pfizer research group

March 2, 1999

Clinical study of La Jolla's lupus drug expanded to Europe and Canada

March 2, 1999

Zimmer launches Orthovisc in Europe; prepares to begin North American trials

Feb. 26, 1999

Rofecoxib up for advisory committee review this spring

Feb. 26, 1999

Clinically effective antiarthritic drug offered for licensing by KS Biomedix

Feb. 26, 1999

Preclinical study confirms antiinflammatory activity of raxofelast

Feb. 25, 1999

ICE/ced-3 cysteine protease inhibitors in development at Idun

Feb. 25, 1999

Connetics begins pivotal trial of relaxin for scleroderma therapy

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...